Health economic modelling for rare disease treatments where no relevant data exists

How do you develop a health economic model if the disease area is so rare that no relevant data exist for it outside of the trial? Calum Jones (Consultant Health Economist, Mtech Access) shares some tips.
Watch the full webinar where we explore the strategic and tactical challenges facing orphan medicines looking to achieve market access, at: mtechaccess.co...